Covid-19: 10 hospitals across India to conduct phase III clinical trial of Favipiravir drug | coronavirus outbreak News,The Indian Express

Covid-19: 10 hospitals across India to conduct phase III clinical trial of Favipiravir drug | coronavirus outbreak News,The Indian Express

Covid-19: 10 hospitals across India to conduct phase III clinical trial of Favipiravir drug

By: Express News Service | Mumbai | Updated: May 14, 2020 at 7:20 pm

In India 150 patients will be undergoing the trial, a 14 day dosage will be administered on patients. The phase III trial results are expected by July-August period this year.